Your GLP-1 Stopped Working. Here Is What to Check Before Raising the Dose.
A stall on a GLP-1 is not automatically a signal to escalate. What to check first, why the highest dose is not the goal, and when raising it is the right answer.
A patient messaged me at week eleven. The scale had not moved in three weeks and she wanted the next dose. It was a reasonable request and it was the wrong question, and the difference between those two things is most of this article.
Four weeks at the same dose is not, by itself, a reason to go up. Nor is a stall. The dose that works is not the highest dose you can tolerate, it is the lowest one that is still doing the job, and telling those apart requires looking at more than a number on a scale.
First: a plateau is expected
Weight loss on these medications is not linear and was never going to be. The curve is steep early and flattens, and in the trials it continues flattening for more than a year before settling. A three-week stall at week eleven is not the medication failing. It is the shape of the curve.
Your body is also doing exactly what bodies do when they lose weight, which is to reduce energy expenditure as mass falls and to raise the hormonal signals that drive hunger. That happens on medication too. It is covered properly in what actually happens when you crash diet, and the mechanism is the same here.
What I check before touching the dose
Is the appetite effect still there? This is the question that matters most and the one nobody asks. If you are still not thinking about food constantly, the medication is working whatever the scale says, and the problem is somewhere else. If the food noise has genuinely returned, that is a pharmacological signal and it is a real argument for escalation.
Those are two completely different situations producing the same stalled number.
Protein. Appetite suppression makes it easy to eat far less protein without noticing, and inadequate protein on a GLP-1 means losing the wrong tissue. This is the most common thing I find and it is covered in the muscle question nobody raises.
What the loss is made of. Someone who has lost four pounds of fat and gained two of muscle has a nearly static scale and an excellent outcome. The scale cannot tell you which is happening and a body composition measurement can, which is the argument in DEXA and body composition scans.
Fibre, fluid and bowel habit. Not a side issue. Slowed gastric emptying plus reduced intake plus low fluid produces constipation reliably, and people reduce their food further in response, which makes everything worse.
Micronutrients. Eating substantially less for months has consequences that do not show up on a scale and do show up in how you feel.
Resistance training. If it is not happening, the stall is partly a muscle problem and a higher dose will not fix a muscle problem.
Side effects you have stopped mentioning. People normalise nausea and reflux remarkably fast. If you are already uncomfortable at this dose, escalating buys worse symptoms for an uncertain gain.
When raising it is the right answer
I am not against escalation. I am against escalation as a reflex.
Go up when the appetite effect has genuinely faded rather than the scale having paused, when you are tolerating the current dose comfortably, when the things above are actually in place, and when you have not reached the top of the range already. Those conditions together are a real indication and I act on them.
Escalating faster than the labelled schedule mostly produces gastrointestinal side effects rather than faster loss, and people who feel terrible stop taking the medication, which is the worst outcome available.
The dose you want is not the dose on the box
There is a maximum licensed dose for each of these drugs. There is no rule that you should reach it. A patient doing well with preserved muscle and tolerable side effects on a middle dose is in a better position than one at maximum who feels unwell and has lost lean tissue, even if the second scale reads lower.
And the dose you can stay on for two years beats the dose you abandon in four months. Whatever these medications do, they do it while you are taking them. The plan around them is what decides what happens afterwards, which is the argument in a GLP-1 prescription is not a treatment plan.
What I told my patient
I asked whether she was still thinking about food the way she had been in month one. She was not. We checked her protein, which was around half of what it needed to be, and her training, which had stopped when the appetite suppression made her feel tired.
We fixed those two things and held the dose. The scale moved again within a month, and more importantly the next body composition measurement showed the loss was coming from where it should. She never needed the higher dose. She needed somebody to look at the other seven things first.
Sources: FDA prescribing information · NIDDK, Weight Management
If any of this sounds like your experience, you can book a virtual consultation with Dr. Sater to review your history and testing in full.
This article is educational and is not individual medical advice. Speak with a qualified physician about your own health before making changes to your care.